Login / Signup

Glutamic acid decarboxylase antibodies in neurocritical patients: a culprit or a bystander?

Dongmei WangKaibin HuangZhenzhou LinYongfang ZhangGuanghui LiuYongming WuShengnan Wang
Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2020)
Most neurocritical patients with serologically positive GAD-Abs had other specific autoimmune antibodies. All patients responded well to immunotherapy, but not parallel to the titers of GAD-Abs. These results indicated that GAD-Abs might be more a bystander than a culprit in neurocritical patients, suggesting that an underlying autoimmune disease should be explored.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • peritoneal dialysis
  • multiple sclerosis
  • patient reported outcomes
  • patient reported